SEC Form 4/A · accession 0001209191-15-026712
PHARMACYCLICS INC · PCYC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Maky Zanganeh
Officer — Chief Operating Officer
Period of report
Mar 11, 2015
Accepted (ET)
Mar 16, 2015 · 8:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000949699
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 11, 2015 | M | 30,000 | $7.19 | A | 255,312 | D | |
| Common Stock | Mar 11, 2015 | S | 30,000 | $254.1148 | D | 225,312 | D | |
| Common Stock | Mar 12, 2015 | M | 92,500 | $0.75 | A | 317,812 | D | |
| Common Stock | Mar 12, 2015 | M | 48,219 | $2.30 | A | 366,031 | D | |
| Common StockF1 | holding | — | — | — | 75,363 | I | Custodian | |
| Common Stock | holding | — | — | — | 900 | I | By Indvidual Retirement Account | |
| Common Stock | holding | — | — | — | 725 | I | By Roth Individual Retirement Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $7.19 | Mar 11, 2015 | M | 30,000 | D | Apr 11, 2010 | Apr 11, 2020 | Common Stock | 30,000 | 114,069 | D |
| Stock Option (Right to Buy)F2 | $2.30 | Mar 12, 2015 | M | 48,219 | D | Sep 10, 2008 | Sep 10, 2018 | Common Stock | 48,219 | 0 | D |
| Stock Option (Right to Buy)F2 | $0.75 | Mar 12, 2015 | M | 92,500 | D | Mar 3, 2009 | Mar 3, 2019 | Common Stock | 92,500 | 37,500 | D |
Explanation of responses
- F1By Reporting Person for minor child.
- F2This option is fully vested.